LWM
Lionsbridge Wealth Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-36,244
| Closed | -$1.49M | – | 52 |
|
|
2023
Q1 | $1.49M | Sell |
36,244
-943
| -3% | -$38.7K | 1.37% | 28 |
|
|
2022
Q4 | $1.52M | Buy |
37,187
+10,217
| +38% | +$418K | 1.48% | 25 |
|
|
2022
Q3 | $1.08M | Buy |
26,970
+496
| +2% | +$19.9K | 1.55% | 20 |
|
|
2022
Q2 | $1.11M | Sell |
26,474
-2,037
| -7% | -$85.5K | 1.28% | 24 |
|
|
2022
Q1 | $1.29M | Sell |
28,511
-1,069
| -4% | -$48.4K | 1.49% | 32 |
|
|
2021
Q4 | $1.37M | Sell |
29,580
-317
| -1% | -$14.6K | 1.47% | 37 |
|
|
2021
Q3 | $1.42M | Sell |
29,897
-77
| -0.3% | -$3.65K | 1.53% | 35 |
|
|
2021
Q2 | $1.55M | Buy |
29,974
+6,667
| +29% | +$345K | 1.66% | 20 |
|
|
2021
Q1 | $1.17M | Buy |
23,307
+898
| +4% | +$45.2K | 1.14% | 41 |
|
|
2020
Q4 | $1.17M | Buy |
22,409
+887
| +4% | +$46.2K | 1.26% | 34 |
|
|
2020
Q3 | $935K | Buy |
21,522
+4,678
| +28% | +$203K | 1.12% | 33 |
|
|
2020
Q2 | $723K | Buy |
+16,844
| New | +$723K | 0.81% | 39 |
|